Anzeige
Mehr »
Login
Mittwoch, 25.12.2024 Börsentäglich über 12.000 News von 680 internationalen Medien
Während die Wall Street über Krypto-ETFs debattiert, liefert dieses Unternehmen 1.000?% RENDITE!!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1JLYP | ISIN: KYG211081248 | Ticker-Symbol: 2M7C
Stuttgart
23.12.24
08:13 Uhr
0,900 Euro
+0,005
+0,56 %
Branche
Gesundheitswesen
Aktienmarkt
ASIEN
1-Jahres-Chart
CHINA MEDICAL SYSTEM HOLDINGS LTD Chart 1 Jahr
5-Tage-Chart
CHINA MEDICAL SYSTEM HOLDINGS LTD 5-Tage-Chart
RealtimeGeldBriefZeit
0,9000,93023.12.
0,8950,93023.12.

Aktuelle News zur CHINA MEDICAL SYSTEM Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
09.12.China Medical System Holdings Ltd.: First Prescriptions for Innovative Drug Lumeblue Issued in China69SHENZHEN, CHINA, Dec. 08, 2024 (GLOBE NEWSWIRE) -- On 6 December, China Medical System Holdings Limited ("CMS" or the "Group") is pleased to announce that the first prescriptions for the innovative...
► Artikel lesen
02.12.China Medical System Holdings Ltd. Gained Exclusive Commercialization Right of Class 1 Innovative Drug Targeting Gout and Hyperuricemia101SHENZHEN, CHINA, Dec. 02, 2024 (GLOBE NEWSWIRE) -- China Medical System Holdings Limited (the "Company", together with its subsidiaries, the "Group" or "CMS") is pleased to announce that on 2 December...
► Artikel lesen
02.12.CMS (00867): VOLUNTARY AND BUSINESS UPDATE ANNOUNCEMENT GAINING EXCLUSIVE COMMERCIALIZATION RIGHT OF CLASS 1 INNOVATIVE DRUG FOR THE TREATMENT OF GOUT ...1
27.11.CMS (00867): VOLUNTARY AND BUSINESS UPDATE ANNOUNCEMENT APPROVAL OF DRUG CLINICAL TRIALS FOR INNOVATIVE DRUG DUAL AGONIST OF GLUCAGON-LIKE PEPTIDE-1 RECEPTOR/GLUCAGON ...-
05.11.CMS (00867): VOLUNTARY AND BUSINESS UPDATE ANNOUNCEMENT NEW DRUG APPLICATION OF RUXOLITINIB PHOSPHATE CREAM FOR VITILIGO APPROVED IN HONG KONG-
18.10.China Medical System Holdings Ltd.:First Ruxolitinib Cream's Prescriptions for Vitiligo Issued in the Greater Bay Area1
24.09.China Medical System Holdings Ltd.: New Drug Application for Vitiligo Indication of Ruxolitinib Phosphate Cream Accepted in China349SHENZHEN, CHINA, Sept. 24, 2024 (GLOBE NEWSWIRE) -- China Medical System Holdings Limited (the "Company", together with its subsidiaries, the "Group" or "CMS") is pleased to announce that on September...
► Artikel lesen
24.09.CMS (00867): VOLUNTARY AND BUSINESS UPDATE ANNOUNCEMENT NEW DRUG APPLICATION FOR VITILIGO INDICATION OF RUXOLITINIB PHOSPHATE CREAM ACCEPTED IN CHINA1
CHINA MEDICAL SYSTEM Aktie jetzt für 0€ handeln
30.08.CMS (00867): INTERIM REPORT 20241
29.08.Dividendenbekanntmachungen (29.08.2024)10.509 Unternehmen  ISIN-Code  Dividende (Währung)  Dividende (EUR)  ABC-MART INC  JP3152740001  33 JPY  0,2055 EUR  ADASTRIA CO LTD  JP3856000009  35 JPY  0,218 EUR  AEON CO LTD  JP3388200002  20 JPY  0...
► Artikel lesen
16.08.China Medical System Holdings Ltd. (00867) Released its 2024 Interim Results: Steady Increase in Revenue and Profit Compared with 2H 2023200SHENZHEN, CHINA, Aug. 15, 2024 (GLOBE NEWSWIRE) -- On August 15, 2024, China Medical System Holdings Limited ("CMS" or the "Company") released its 2024 interim results announcement, with a steady...
► Artikel lesen
15.08.CMS (00867): LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION1
15.08.CMS (00867): INTERIM DIVIDEND FOR THE SIX MONTHS ENDED 30 JUNE 20241
15.08.CMS (00867): INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2024 AND RE-DESIGNATION OF DIRECTOR1
05.08.China Medical System Holdings Ltd.: NDA for Additional Rheumatoid Arthritis Indication of Methotrexate Injection Approved in China147SHENZHEN, CHINA, Aug. 05, 2024 (GLOBE NEWSWIRE) -- China Medical System Holdings Limited (the "Company", together with its subsidiaries, the "Group" or "CMS") is pleased to announce that on 30 July...
► Artikel lesen
05.08.CMS (00867): VOLUNTARY AND BUSINESS UPDATE ANNOUNCEMENT NEW DRUG APPLICATION FOR ADDITIONAL RHEUMATOID ARTHRITIS (RA) INDICATION OF METHOTREXATE INJECTION ...-
05.08.CMS (00867): NOTICE OF BOARD MEETING-
19.07.CMS (00867): LETTER TO NON-REGISTERED SHAREHOLDERS - ARRANGEMENT OF ELECTRONIC DISSEMINATION OF CORPORATE COMMUNICATIONS AND REPLY-
19.07.CMS (00867): LETTER TO REGISTERED SHAREHOLDERS - ARRANGEMENT OF ELECTRONIC DISSEMINATION OF CORPORATE COMMUNICATIONS AND REPLY FORM1
16.07.China Medical System Holdings Ltd. (867.HK) Reincluded in S&P Global Sustainability Yearbook (China Edition) and Maintained MSCI ESG "AA" Rating2
Seite:  Weiter >>
28 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1